NCT00991692

A Multisite Trial of ACQUIREc Therapy

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: University of Alabama at Birmingham · Academic / Other
• Sex: All
• Age: 3 Years – 8 Years
• Healthy volunteers: Not accepted

Summary

A multisite trial to testing different dosage levels of a systematic form of Pediatric Constraint-Induced (CI) Therapy called ACQUIREc Therapy. The high dosage treatment involved 6 hours of daily therapy services for 21 days. This was compared to a moderate dosage level of 3 hours of daily therapy services for 21 days. It was hypothesized that children receiving the higher therapy dosage would have greater and more clinically significant benefits from ACQUIREc Therapy but that both groups of children would benefit from the therapy services.

Conditions

• Hemiparetic Cerebral Palsy

Interventions

Type	Name	Description
OTHER	Therapy services (ACQUIREc Therapy)	Dosage levels that are associated with the efficacy of intensive therapeutic services provided by OT and PT professionals.

Timeline

• Start date: 2008-06-01
• Primary completion: 2009-08-01
• Completion: 2009-10-01
• First posted: 2009-10-08
• Last updated: 2009-10-08

Locations

1 site across 1 country: United States